- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Ediscovery
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Litigation Support Services
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
-
January 15, 2021Robins Kaplan Partners Named to IAM Strategy 300 Global Leaders Guide
-
January 12, 20212025 Goals - Our commitment to Inclusion, Diversity, and Equity
-
January 5, 2021Litigator Mark Hallberg Joins Robins Kaplan LLP
-
January 28, 2021COVID-19: The Show Did Not Go On
-
February 9, 2021Smart Phone Privacy and Data Security – How to Assess and Minimize Risk in the Current Reality
-
March 6, 2021With Our Voices 2021 Arc Gala
-
December 27, 2020Covid-19 Relief Bill Provides Long-Awaited Funding to Small Businesses and Individuals
-
December 17. 2020Covid-19 Divorce and Marital Property Agreements
-
Fall 2020COVID Immunity: No, Not That Kind of Immunity
-
January 22, 2021Financial Daily Dose 1.22.2021 | Top Story: Google Threatens to Pull Search From Down Under Over Proposed Law
-
January 21, 2021Financial Daily Dose 1.21.2021 | Top Story: Wall Street Greets Biden Administration With Rally, Records on Stimulus Hopes
-
January 20, 2021Financial Daily Dose 1.20.2021 | Top Story: Netflix Hits 200M Subscribers, Halts Massive Borrowing
Science Advisors
To best protect and defend innovation in litigation, we know that our clients need representation that combines courtroom mastery with deep technical expertise. Over the last two decades, Robins Kaplan LLP has cultivated an in-house team of scientific and engineering advisors to help us stay at the forefront of technology and the fast-evolving IP litigation landscape. Our team holds Ph.D.’s spanning a wide range of scientific disciplines. This depth enables us to delve into the scientific aspects that underpin our clients’ technologies.
Since underlying science permeates patent cases and other intellectual property matters, our in-house scientists provide technical assistance and insight at every stage of representation in complex IP cases, monetization of IP assets, and trade secret protection.
Many of our science advisors are registered to practice before the U.S. Patent and Trademark Office as patent agents. On behalf of our clients, they also work alongside our attorneys to educate and present intricate issues, help translate complex technology, and communicate the legal implications of conclusions into terms judges and juries can understand.
Our science advisors provide assistance with:
- Case Strategy
- Claim Construction Strategy
- Discovery Strategy
- Trial Strategy
- Assessing Research Scientific Opinions
- Early-case Assessment
- Patent-claim Analysis
- Forensic Analysis
- Source Code Inspection
- Expert Witness Preparation
- Trial Exhibit Creation
- Drafting Summary Judgments
- Drafting Technical Briefs
- Drafting Inventor Declarations
Offering Ph.D. Level Expertise in:
- Electrical Engineering
- Computer Science
- Materials Science
- Chemistry
- Chemical Engineering
RELATED PROFESSIONALS
Shelley R. Gilliss, Ph.D.
Chief Business Intelligence Officer
Joseph (Yu) Chen, Ph.D.
Science Advisor
Bahareh Elahian, PH.D.
Science Advisor
Alice Mendelsohn Ribbens, Ph.D.
Senior Scientist
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.